跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 836 条关于
“CD84”
全部
836
临床试验
612
药物
164
机构
0
资讯
60
7个月前
Gyala Therapeutics Launches First-in-Class CD84-Targeted CAR-T Trial for Relapsed Acute Leukemias
去年
Gyala Therapeutics Advances First-in-Class CD84-Targeting CAR-T Therapy with €3 Million Funding for AML and T-ALL Treatment
5年前
CDK4/6 Inhibitors Show Potential in HR+/HER2- Early Breast Cancer Adjuvant Therapy
去年
Siremadlin Plus Ribociclib Shows Promise in MDM2/CDK4-Amplified Liposarcoma
去年
Pheast's PHST001, Targeting CD24 'Don't Eat Me' Signal, Enters First-in-Human Trials
5个月前
Pheast Therapeutics Advances PHST001 Anti-CD24 Antibody into Phase 1b Combination Trials
去年
Machine Learning Model Predicts CDK4/6 Inhibitor Response in Metastatic Breast Cancer
去年
mRNA Delivery to CD34+ Cells via Lipid Nanoparticles Shows Promise in Rhesus Monkeys
去年
Delaying CDK4/6 Inhibitors in Breast Cancer Reduces Toxicity Without Compromising Outcomes
11个月前
Serum CD80 Emerges as Predictive Biomarker for Neoadjuvant Immunotherapy Response in Esophageal Cancer
第 1 页,共 6 页
上一页
下一页